More understanding on the SMARCA4-dNSCLC shed some light on its correlation and effects on co-existence with oncogenic drivers and other tumor suppressor genes as well as possible biomarkers and immune check point inhibitors to determine optimal treatment options for metastatic tumors. This evidence concerns the gene SMARCA4 and neoplasm.